Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial
Titel:
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial
Auteur:
Gay, Francesca Musto, Pellegrino Rota-Scalabrini, Delia Bertamini, Luca Belotti, Angelo Galli, Monica Offidani, Massimo Zamagni, Elena Ledda, Antonio Grasso, Mariella Ballanti, Stelvio Spadano, Antonio Cea, Michele Patriarca, Francesca D'Agostino, Mattia Capra, Andrea Giuliani, Nicola de Fabritiis, Paolo Aquino, Sara Palmas, Angelo Gamberi, Barbara Zambello, Renato Petrucci, Maria Teresa Corradini, Paolo Cavo, Michele Boccadoro, Mario